Authors
Loading...
Systematic review finds no increased risk of hepatocellular carcinoma recurrence with direct-acting antivirals, suggesting positive outcomes for chronic hepatitis C treatment.
Lindsley et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: